` 0RH2 (El En SpA) vs DAX Index Comparison - Alpha Spread

0RH2
vs
D
DAX Index

Over the past 12 months, 0RH2 has underperformed DAX Index, delivering a return of -11% compared to the DAX Index's +13% growth.

Stocks Performance
0RH2 vs DAX Index

Loading
0RH2
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
0RH2 vs DAX Index

Loading
0RH2
DAX Index
Difference
www.alphaspread.com

Performance By Year
0RH2 vs DAX Index

Loading
0RH2
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
El En SpA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

El En SpA
Glance View

Market Cap
294.8m EUR
Industry
Health Care

El.En.SpA operates as a holding company, which engages in the production, research and development, distribution, and sale of laser systems. The company is headquartered in Calenzano, Firenze. The company went IPO on 2000-12-11. The company controls a group of companies active in the manufacture, research, development, distribution and sale of laser equipment.The Company's range of products includes laser systems for dermatology, surgery, cosmetics, physiotherapy, dentistry and gynaecology, laser systems for cutting, marking and welding of metals, wood, plastic and glass; decoration of leather and fabrics, conservative restoration of works of art. The firm also offers accessories, after-sale services and consulting in the related areas.

0RH2 Intrinsic Value
10.72 EUR
Overvaluation 17%
Intrinsic Value
Price €12.9
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett